Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 16,408.54 -16.31 -0.10%
S&P 500 1,864.85 2.54 0.14%
NASDAQ 4,095.52 9.29 0.23%
Ticker Volume Price Price Delta
STOXX 50 3,155.81 16.55 0.53%
FTSE 100 6,625.25 41.08 0.62%
DAX 9,409.71 91.89 0.99%
Ticker Volume Price Price Delta
NIKKEI 14,539.26 22.99 0.16%
TOPIX 1,172.51 -0.86 -0.07%
HANG SENG 22,760.24 64.23 0.28%

RECKITT BENCKISER GROUP PLC: Directorate Change


12 June 2013

Reckitt Benckiser Group plc

DIRECTORATE CHANGE

It is with regret that Reckitt Benckiser Group plc (RB) today announces the resignation of Graham Mackay as a director, and the Senior Independent Director, with immediate effect.

As was announced by SABMiller plc in April, Mr Mackay has recently undergone surgery for a brain tumour and is now receiving further treatment. As a result, Mr Mackay has expressed a wish to reduce his business commitments and has tendered his resignation to the RB Board.

Adrian Bellamy, Chairman of RB, commented:

"Graham has been a valued member of our Board and our Remuneration Committee since February 2005 and we thank him for his immense contribution and wise counsel over the last eight years. We also thank him for acting as our Senior Independent Director since November 2006. We fully respect and understand his decision to step down from the Board and I, on behalf of the Board and I am sure also on behalf of our shareholders, wish him well as he continues his treatment. Our thoughts are with him and his family."

Following Mr Mackay's resignation, with immediate effect the Board has appointed Andre Lacroix as the new Senior Independent Director. Mr Lacroix, the current CEO of Inchcape plc, has been a director of RB since October 2008 and is a member of the Audit Committee.

For further information:

Elizabeth Richardson

Company Secretary

Telephone +44 (0) 1753 217 800

Notes for Editors:

Reckitt Benckiser (RB) is a global consumer goods leader in health, hygiene and home.

With a purpose of delivering innovative solutions for healthier lives and happier homes, RB is in the top 25 of companies listed on the London Stock Exchange. Today it is the global No 1 or No 2 in the majority of its fast-growing categories, driven by an exceptional rate of innovation. Its health, hygiene and home portfolio is led by 19 global Powerbrands including Nurofen, Strepsils Gaviscon, Mucinex, Durex, Scholl, Lysol, Dettol, Clearasil, Veet, Harpic, Bang, Mortein, Finish, Vanish, Woolite, Calgon, Air Wick, and French's. RB has close to half of its revenues coming from it 2 emerging market Areas and just over half from its developed market Area.

RB people and its culture are at the heart of the company's success. They have an intense drive for achievement and a desire to outperform wherever they focus, including in sustainability where the company has reduced its carbon footprint by 20% in 5 years and is now targeting to deliver a 1/3 reduction in water impact, 1/3 further reduction in carbon and to have 1/3 of its net revenue coming from more sustainable products by 2020. RB has been recognised as a sustainability leader in the CDP Global 500 Carbon Performance Leadership Index and received a 2013 Sector Mover Sustainability Award in the 10th Sustainability Yearbook. It is also the Save the Children charity's largest FMCG global partner.

The company has operations in over 60 countries, with headquarters in the UK, Singapore, Dubai and Amsterdam, and sales in almost 200 countries, The company employs approximately 36,000 people worldwide.

For more information visit www.rb.com

END

-0- Jun/12/2013 16:01 GMT

Sponsored Links
Advertisement
Advertisements
Sponsored Links
Advertisement